Epicutaneous presensitization and intrarectal rechallenge with oxazolone leads to oxazolone colitis
Compared with the normal group, mice in experimental groups became lazy, anorectic, and had the symptoms of visual bloody stool, and weight loss after 24 h oxazolone treatment. Histological examination of mouse colons on the third day showed that mice in model group, which developed massive bowel wall edema, developed with a loss of crypts and mucosa membrane shedding. The necrosis of intestinal mucosa membrane of those mice turned into ulcer. The dense infiltration of muscularispropria and serosal layers of the mucosa with lymphocyte were shown in
Figure 1.
Histological examination of colon in the model group under the optical microscope.
A: the normal group without any treatment. The glandular structure was basically normal with a small amount of bleeding and inflammatory cells infiltration.
B: Slight crypts abscess, mucosa membrane falling off to an ulcer, small fibrosis and inflammatory cells infiltration were observed.
C: Slight crypts abscess, mucosa membrane falling off to an ulcer were observed. The ulcer was mainly located in the mucous layer with a lot of inflammatory cells infiltration.
D: The glandular structure disordered. Mucosa membrane became necrosis and falling off and erosions.
E: The glandular structure was normal. Crypts abscess and inflammation cells infiltration were observed.
Inhibition of oxazolone-induced colitis by tetramethylpyrazine is associated with increased apoptosis of mononuclear cells in spleen and lamina propria
The apoptotic rate of SMC, LPMC were significantly lower (
P < 0.05) in oxazolone-induced colitis model group than that in normal group (
Table 2). There was no significant difference in PBMC apoptosis between normal, model group and the tetramethylpyrazine-treated groups (
P > 0.05). Compared with the model group, treatment with tetramethylpyrazine resulted in an increase of SMC and LPMC apoptosis. In middle dose group, apoptotic rate of LPMC which was cultured for 48 h and 96 h were both significantly higher than that in the model group (
P < 0.05), but still lower than that in normal group. There were higher SMC apoptotic rates in high dose group and normal group than that in the model group after both 48 h and 96 h culture.
| Group | 48 h
| 96 h
|
|---|
| SMC | LPMC | PBMC | SMC | LPMC | PBMC |
|---|
| Normal | 4.61±1.19 | 4.23±1.01 | 3.97±0.89 | 3.63±0.46 | 4.93±0.71 | 3.60±0.46 |
| Model | 2.89±0.62* | 0.58±0.21** | 2.69±0.92 | 2.52±0.56 | 0.37±0.10 | 3.49±0.36 |
| Low | 3.35±0.26 | 0.58±0.20** | 3.07±0.67 | 3.10±0.81 | 0.69±0.31** | 3.17±0.61 |
| Middle | 3.34±1.00 | 3.96±1.48** | 3.21±0.56 | 2.78±0.45* | 2.94±0.74*## | 3.30±0.59 |
| High | 5.93±1.68* | 1.20±0.51** | 3.08±1.10 | 3.97±0.54# | 1.03±0.35**# | 3.39±0.76 |
Suppression Effect of tetramethylpyrazine treatment on transcription factors (NF-κB, AP-1 and NF-AT) in SMC, LPMC, and PBMC
Compared to the normal group, oxazolone-induced colitis significantly promoted the expression of AP-1,NF-AT and NF-κB mRNA in SMC, LPMC, PBMC (
P < 0.01,
Table 3,
4,
5). The result showed that there was a non-linear relationship between the dose of tetramethylpyrazine and the expressional level of AP-1, NF-AT, and NF-κB (
Figure 2,
3,
4). Compared with the other groups, AP-1, NF-AT, and NF-κB were most dramatically suppressed in SMC, LPMC and PBMC by the tetramethylprazine treatment in the middle dose group. However, there was significant difference in the mRNA level of AP-1 in SMC, LPMC and PBMC among the three different doses tetramethylpyrazine treated groups (
P < 0.05). Moreover, no significant difference was observed in the mRNA levels of NF-AT and NF-κB in SMC, LPMC and PBMC between normal and middle groups.
| Group | Normal | Model | Low | Middle | High |
|---|
| SMC | 3.22±0.50 | 5.69±0.69** | 5.21±0.59** | 4.10±0.94 | 4.45±0.33**# |
| LPMC | 3.18±0.42 | 5.53±0.95** | 5.20±0.48 ** | 4.54±0.77* | 4.89±0.24 ** |
| PBMC | 3.28±0.32 | 5.72±0.49 ** | 5.22±0.70 ** | 4.31±0.81# | 4.73±0.35 **# |
: P < 0.05,
P < 0.01, compared with normal group.
: P < 0.05,
: P < 0.01, compared with model group.
| Group | Normal | Model | Low | Middle | High |
|---|
| SMC | 3.15±0.69 | 5.71±1.08** | 4.67±0.44* | 4.36±0.51 | 4.54±0.36 * |
| LPMC | 3.06±0.62 | 5.36±0.40 **## | 5.15±0.61 ** # | 3.98±0.17 | 4.47±0.87 |
| PBMC | 3.38±0.72 | 5.68±0.76 **# | 4.90±0.37 | 4.04±0.57 | 4.18±0.47△ |
: P < 0.05,
P < 0.01, compare with normal group;
: P < 0.05,
P < 0.01, compare with middle group
: P < 0.05,compare with model group
| Group | Normal | Model | Low | Middle | High |
|---|
| SMC | 3.65±0.87* | 5.46±0.58 | 4.96±0.40 | 4.38±0.44* | 4.53±0.35 |
| LPMC | 3.96±0.88 | 5.42±0.85 | 5.09±0.90 | 4.39±0.31 | 4.75±0.44 |
| PBMC | 4.05±0.88 | 5.45±1.00 | 5.11±0.45# | 4.28±0.28 | 4.75±1.02 |
P < 0.05, compare with model group;
: P < 0.05, compare with middle group
Comparison of AP-1 mRNA expressional level in SMC, LPMC and PBMC of normal group, model group and tetramethylpyrazine treated group (low dose, middle dose and high dose
RNA was extracted from the cells and qRT-PCR was performed to amplify AP-1 cDNA. The results showed that AP-1 mRNA level were much higher in SMC, LPMC and PBMC of the model group than those in normal group (P < 0.01). Dose-response studies showed that accompanying with a dose increase of tetramethylpyrazine, AP-1 mRNA were down-regulated compared with the model group, but still were higher than that in normal group. At a dose of 1 g/L (middle dose), AP-1 mRNA exhibited inhibition at the greatest degree.
Comparison of NF-κB mRNA expressional level in SMC, LPMC and PBMC of normal group, model group and tetramethylpyrazine treated group (low dose, middle dose and high dose
RNA was extracted from the cells and qRT-PCR was performed to amplify NF-κB cDNA. The results showed that NF-κB mRNA level were significantly higher in SMC, LPMC and PBMC of the model group than those in normal group (P < 0.01). Dose-response studies showed that NF-κB mRNA of SMC in tetramethylpyrazine treated group at low dose and high dose was still higher than that in the normal group (P < 0.05). Only NF-κB mRNA of LPMC in the low dose group was still higher than that both in the normal group and middle dose group (P < 0.01, P < 0.05, respectively). NF-κB mRNA of PBMC in middle dose and high dose group was dramatically lower than that in the model group (P < 0.05).
Comparison of NF-AT mRNA expressional level in SMC, LPMC and PBMC of normal group, model group and tetramethylpyrazine treated group (low dose, middle dose and high dose
RNA was extracted from the cells and qRT-PCR was performed to amplify NF-AT cDNA. NF-AT mRNA of SMC in model group was higher than that in both the normal group and the middle dose group (P < 0.05). There was no difference of NF-AT in LPMC among the groups. NF-κB mRNA of PBMC in middle dose was dramatically lower than that in low dose group (P < 0.05).
Tetramethylpyrazine (ligustrazine) is a kind of alkaloid extracted from Chinese traditional medicine, which can promote Qi-blood circulation and pain relief. It has been widely used in the treatment of spinal cord injury, cerebral ischemic injury (
11) and tumor (
12). A recent study reveals that expression of MyD88, interleukin (IL)-1, IL-23 and IL-6 in mononuclear phagocyte are required for colitis development (
13). Oxazolone is a kind of half antigen which irritates contact allergies. Previous studies indicate that IL-4 is the initial cytokine produced in oxazolone-induced colitis and is rapidly superceded by IL-13 secreted by NK-T cells (
3). In the present study, the effect of tetramethylpyrazine on mononuclear cells from spleen, lamina propria and peripheral blood in oxazolone-induced colitis were evaluated. We observed that mononuclear cells apoptosis in both spleen and lamina propria were reduced by oxazolone-induced progressive colitis. It indicated that both local intestine and the biggest immune organ-spleen were reacted with oxazolone. The apoptosis of SMC and LPMC was increased by tetramethylpyrazine treatment. The result was inconsistent with the previous studies which indicate that tetramethlpyrazine could reduce cell apoptosis in spinal cord via suppressing bcl-2 and caspase 3 (
14,
15). The effect of tetramethylpyrazine on SMC and LPMC was related to dose in a nonlinear regression. The middle dose of tetramethylpyrazine had the most significant effect on the promotion of apoptosis for SMC and LPMC. It was indicated that the efficacy of tetramethlpyrazine was dependent on dose, but the proper therapeutic dose of tetramethlpyrazine for human UC need to be further investigated.
We also observed that the pathogenic pathway leading to tissue injury in oxazolone-induced colitis might be attributed to the production of cytokines. Cytokine expression is generally initiated and regulated at transcriptional level by interactions among specialized nuclear proteins, termed transcription factors and promoter region containing DNA elements that nucleotide sequences. Ap-1 is a dimeric complex of basic region-leucine zipper proteins, which consists of heterodimers or homodimers of Jun, Fos and ATF families. In a large number of genes, AP-1 binds to specific DNA sequences and regulates inflammation and cellular growth (-). NK-AT transcription factor is characterized by a highly conserved DNA binding domain and a calcineurin binding domain. Juan Y,
et al. reported that tetramethylpyrazine plays an anti-inflammatory role, decreases IL-8 production
in-vitro, and blocks ERK1/2 and p38 phosphorylation via suppressing AP-1 (
19).
NF-AT factors play an important role in T cell activation and differentiation. Furthermore, NF-AT factors may also have an effect on the cycle and apoptosis of T lymphocytes. NF-κB, a pro-inflammatory transcription factor, has proved to be a key modulator governing the molecular network, and further leading to various cellular function abnormalities associated with IBD (
20,
21). Compared with healthy control, intestinal tissues from IBD patients have enhanced NF-kB transcriptional activity.
Our data showed that AP-1, NF-AT and NF-kB mRNA in SMC, LPMC and PBMC were higher in the oxazolone-induced model group than those in the normal group. The suppression of AP-1, NF-AT and NF-kB by tetramethlpyrazine might be the molecular mechanism of the reduced apoptosis of mononuclear cells. Our results provided the evidence that AP-1, NF-AT and NF-kB might be the central targets of tetramethlpyrazine with its potent anti-inflammatory activity in oxazolone-induced colitis mice.